Evidence map›Paper›PMID 40540531›Full record

ArticlePLoS pathogens2025

SARS-CoV-2 remodels the Golgi apparatus to facilitate viral assembly and secretion.

Jianchao Zhang, Andrew Kennedy, Daniel Macedo de Melo Jorge, Lijuan Xing, Whitney Reid, Sarah Bui, Joseph Joppich, Molly Rose, Sevval Ercan, Qiyi Tang and 3 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. COVID-19 Prophylactic Effect of Bromhexine Hydrochloride.Immunity, inflammation and disease · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Lysosomes' fallback strategies: more than just survival or death.Frontiers in cell and developmental biology · 2025
    Review
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Jianchao ZhangDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0002-3269-4639
Andrew KennedyDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Daniel Macedo de Melo JorgeDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Lijuan XingDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
Whitney ReidDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
Sarah BuiDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
Joseph JoppichDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
Molly RoseDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
Sevval ErcanDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
Qiyi TangDepartment of Microbiology, Howard University College of Medicine, Washington, DC, United States of America.
David GinsburgLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Andrew W TaiDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.ORCID 0000-0002-6877-450X
Yanzhuang WangDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0002-1864-7094

Funding

Sleep Disorders in Adults with Sickle Cell Disease: Frequency, Associations with Cardiovascular and Pain Indicators, and Responses to TreatmentU54MD007597 · NIMHD · HOWARD UNIVERSITY · PI William M. Southerland · 2019 to 2026
$37.7M
The Molecular Genetics of HemostasisR35HL171421 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Ginsburg · 2024 to 2026
$2.8M
Dysregulation of p97/VCP disease mutants in IBM and FTLD-UR01NS102279 · NINDS · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI CHOU, TSUI-FEN · 2018 to 2022
$2.8M
Supplement: GOLGI BIOGENESIS AND FUNCTIONR35GM130331 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, YANZHUANG · 2019 to 2023
$2.7M
How flaviviruses hijack a host transmembrane protein chaperone to promote viral infectionR01GM139823 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TAI, ANDREW W. · 2021 to 2024
$1.4M
HIV-1 Genomic RNA IntegrityR21AI152865 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIDD, JEFFREY M, TAI, ANDREW W. · 2020 to 2021
$429k
NHLBI NIH HHS R35 HL171421NIAID NIH HHS R21 AI152865NIGMS NIH HHS R01 GM139823NIGMS NIH HHS R35 GM130331NIMHD NIH HHS U54 MD007597NINDS NIH HHS R01 NS102279
6 · The paper itself

Abstract

The COVID-19 pandemic is caused by the enveloped virus SARS-CoV-2. Despite extensive investigation, the molecular mechanisms for its assembly and secretion remain largely elusive. Here, we show that SARS-CoV-2 infection induces global alterations of the host endomembrane system, including dramatic Golgi fragmentation. SARS-CoV-2 virions are enriched in the fragmented Golgi. Blocking endoplasmic reticulum (ER) to Golgi trafficking dramatically inhibits SARS-CoV-2 assembly and secretion without reducing viral genome replication. Significantly, SARS-CoV-2 infection down-regulates GRASP55 but up-regulates TGN46 protein levels. Surprisingly, GRASP55 expression reduces both viral secretion and spike number on each virion without affecting viral entry, while GRASP55 depletion displays opposite effects. In contrast, TGN46 depletion only inhibits viral secretion without affecting spike incorporation into virions. Taken together, we show that SARS-CoV-2 alters Golgi structure and function to modulate viral assembly and secretion, highlighting the Golgi as a potential therapeutic target for blocking SARS-CoV-2 infection.

Indexed as

COVID-19Golgi ApparatusSARS-CoV-2Virus AssemblyVirus ReleaseAnimalsChlorocebus aethiopsEndoplasmic ReticulumHumansMembrane ProteinsSpike Glycoprotein, CoronavirusVero CellsVirus ReplicationMembrane ProteinsSpike Glycoprotein, Coronavirus

Identifiers

PMID40540531
PMCPMC12208438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.